About this trial
This study aims to investigate the optimal oxygen flow rate needed during tracheal intubation with the C-MAC video laryngoscope (Karl Storz, Tuttlingen, Germany) using Miller-blade or Macintosh-blade size No. 0 or No. 1 in the operating room or intensive care unit. The investigators hypothesize that the difference between low-flow and high-flow supplemental oxygen is negligible.
Eligibility criteria
Qualifiers
Pediatric patients requiring oral or nasal tracheal intubation for elective, semi-elective, or urgent surgical and non-surgical indications.
Neonates and infants up to 52 weeks postconceptual age, with legal guardians providing written informed consent before the intervention
Disqualifiers
Prediction of difficult intubation upon physical examination or previous history of difficult intubation, mandating a technique different than direct laryngoscopy to secure the airway;
Congenital heart disease demanding FiO2 < 1.0
Cardiopulmonary collapse requiring advanced life support
Intubation for emergency surgical and non-surgical indications.
Trial design
Treatments tested in this trial
- Low-flow nasal supplemental oxygen with a conventional nasal cannula during tracheal intubation with the C-MAC video laryngoscope
- High-flow nasal supplemental oxygen (Fisher & Paykel, Auckland, New Zealand) during tracheal intubation with the C-MAC video laryngoscope
Treatment groups
Sponsors and collaborators
Thomas Riva
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Sponsor institution
University Hospital, Geneva
Collaborator
Kantonsspital Aarau
Collaborator
Centre Hospitalier Universitaire Vaudois
Collaborator
Charite University, Berlin, Germany
Collaborator
Perth Children's Hospital
Collaborator
The Hospital for Sick Children
Collaborator
Istituto Giannina Gaslini
Collaborator
Cantonal Hospital of Lucerne
Collaborator
Children's Hospital of Philadelphia
Collaborator
Montreal Children's Hospital of the MUHC
Collaborator